My commentary in @ConversationCA highlights lessons from climate change for the UNGA High-level Meeting on AMR:
1️⃣ Adopt unifying goals to rally public and political support
2️⃣ Create a scientific panel to provide policymakers with the evidence they need
https://t.co/g2esjr37ov
The 2025 AMR Policy Accelerator Impact Report is out!
Look back on our year dedicated to:
🔸advancing AMR global governance
🔸actioning evidence-informed national policymaking, and
🔸strengthening AMR policymaking capacity
➡️ https://t.co/Co7nUEm7vH
@YorkUniversity
🔎Just published in @GlobalHealthBMJ! Our new paper (in collaboration with @KSAU_Ottawa ) explores how COVID-19 shaped antimicrobial resistance (AMR). Read here🔗 https://t.co/JDccJplyHE
#AMR#OpenAccess
The Independent Panel on Evidence for Action Against AMR (IPEA) is foundational for global action against AMR.
Our policy brief with @ESCMID highlights how IPEA can deliver policy-relevant evidence.
Some key take-aways:
How can IPEA, launching this December, maximize its outputs to be timely, credible & equitable?
This policy brief with @ESCMID explores how IPEA can organize its scientific work to ensure relevant, policy-responsive evidence on #AMR.
📚https://t.co/KvieiH8Wp5
⏰Nov 20: Don’t miss this #WAAW2025 webinar bringing together artists & storytellers to share how their work, including comics, games & immersive storytelling, is building public awareness & inspiring action on #AMR.
Learn more & register: https://t.co/dYCzgV5iCu
Applications are due in two weeks!
This position will further strengthen @YorkUHealth's capacity around implementation science, with @kerfully's appointment last year as an Assistant Professor in Implementation Science and Knowledge Mobilization.
How do gender dynamics impact health outcomes related to antimicrobial resistance (#AMR)? 💊🌎
For a quick overview of our study, explore the summary: https://t.co/UIHeOU4F2Y
#GenderAndAMR
The IPSA (@ipsa_aisp) World Congress kicks off in Seoul! GSL’s Gabriel Fezza & @MathieuJPP will present research on how institutional, economic & political factors shape the effectiveness of international laws.
📌Join their panel July 15, 3:30 PM KST @ Coex [3F 308B]. #IPSA2025
New research coming out of Global Strategy Lab ahead of World No Tobacco Day finds a lack of a gender lens in most tobacco control research, despite men and women having different smoking behaviours. https://t.co/BwcbYGkFhf @gstrategylab@MathieuJPP@YorkUHealth
#AntimicrobialResistance kills millions, and no country can tackle it alone. In #BellagioBreakthroughs, I discuss how the 1-10-100 goals can help forge global consensus and create equitable, win-win solutions. https://t.co/GKweOJYOob
🌍 Now available in @PLOSGPH - Intergovernmental or Fully Independent? Designing a Scientific Panel on Evidence for Action Against Antimicrobial Resistance.
Draws on successes & failures from #IPCC & tables 2 design options for a scientific panel on #AMR.
https://t.co/ByDmdOTil1
DEADLINE EXTENDED: the new deadline for this opportunity is now December 2, 2024. Please get in touch with Search Committee Chair (Dr. Benedict Weobong) if you have any questions.
Discover how the arts can elevate understanding, fuel awareness, and inspire collaboration on the urgent global health and development challenge of antimicrobial resistance.
📅 Nov 20
⏰ 11 AM EST / 4 PM GMT
Register here: https://t.co/46h4l4OdkU
#WAAW2024#AMR
What can AMR experts learn from the Montreal Protocol? Join us ahead of #WAAW2024 for a webinar discussion exploring how the successful governance principles of the Montreal Protocol can inform & enhance strategies for managing antimicrobial resistance ➡ https://t.co/xOdnoLS36l
This #WAAW2024 join the AMR Policy Accelerator & @cfd_center for a webinar on antimicrobial access, equity & humanitarian crisis.
🗓️ November 21, 2024
⏲️ 9am EST/ 3pm CET
More info & register: https://t.co/RlUkufL9Bx
#amr#amrpolicy@MSF
Excited to share our latest in @equityhealthj. We analyze over 280,000 deaths and nearly 10 million COVID-19 cases across 608 neighbourhoods to understand how epidemics are shaped by social inequities in the eight largest cities in Canada and Latin America https://t.co/wwtyaQlU4J
Social inequities fueled COVID-19 infections and deaths in the eight largest cities of the Americas. Read GSL’s latest publication, ‘Social epidemiology of urban COVID-19 inequalities in Latin America and Canada’ in @equityhealthj ➡ https://t.co/igCwLxQOLS
Social inequities fueled COVID-19 infections and deaths in the eight largest cities of the Americas. Read GSL’s latest publication, ‘Social epidemiology of urban COVID-19 inequalities in Latin America and Canada’ in @equityhealthj ➡ https://t.co/igCwLxQOLS